Erly Sign
We’re passionate about health-tech that makes diagnostics more accessible. ErlySign is pioneering a breakthrough in early cancer detection with India's first saliva-based oral cancer test, delivering rapid, non-invasive results in just 15 minutes. After securing significant funding and regulatory approvals, ErlySign is scaling clinical trials and partnerships with leading oncology centers to bring affordable, accessible diagnostics across urban and rural India. Their innovative biomarker technology promises to dramatically improve early intervention outcomes and reduce the burden of oral cancer, the third most common cancer in India. With advanced labs and ongoing R&D into multi-cancer detection, ErlySign represents a transformative leap in healthcare diagnostics.
